Chronic Migraine: Why we Get it Wrong, Why it Matters

News
Slideshow

Episodic or chronic? Distinguishing between the 2 types of migraine is essential to ensure optimal treatment. Meet Abigail and Martin. Who has which headache?  

Recent Videos
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Migraine Management Pearls for Primary Care with Neurologist Jessica Ailani, MD
Migraine-specific therapies belong in primary care setting, Jessica Ailani, MD
Related Content
Machine Learning Identifies Risk Factors for Severe Cognitive Decline During Menopause / image credit image credit ©New Africa/stock.adobe.com

Machine Learning Identifies Risk Factors for Severe Cognitive Decline During Menopause

Grace Halsey
January 16th 2025
Article

The effective approach to identifying risk for the disruptive cognitive issues holds promise for development of early intervention to mitigate decline.

Distress Signals: How to Help a Clinician Colleague in Need

Distress Signals: How to Help a Clinician Colleague in Need

Sydney Jennings
February 14th 2023
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Rebekah Bernard, MD, a family physician and national speaker on physician wellness.

Higher Daily Step Count Linked to Lower Risk for Depression: Daily Dose / image credit: ©New Africa/AdobeStock

Higher Daily Step Count Linked to Lower Risk for Depression: Daily Dose

Sydney Jennings
January 15th 2025
Article

Your daily dose of the clinical news you may have missed.

Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management

Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management

Sydney Jennings
September 29th 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.

Minimal Distress Reported with Multi-Cancer Early Detection Testing: New Findings from PATHFINDER Trial / Image credit: ©Christoph Burgstedt/AdobeStock

Minimal Distress Reported with Multi-Cancer Early Detection Testing: New Findings from PATHFINDER Trial

Sydney Jennings
January 14th 2025
Article

A new analysis of patient reported outcomes from the PATHFINDER study indicate the potential clinical benefit of early cancer detection.

The FDA Accepts Eisai BLA for Lecanemab Subcutaneous Maintenance Dosing

The FDA Accepts Eisai BLA for Lecanemab Subcutaneous Maintenance Dosing in Adults with Alzheimer Disease

Grace Halsey
January 14th 2025
Article

Weekly SC injection of lecanemab is expected to maintain clinical and biomarker benefits reached during the IV initiation phase. The PDUFA date is Aug 31, 2025.

© 2025 MJH Life Sciences

All rights reserved.